Association Between Autoimmune Thyroiditis and Cervical Artery Dissection: A Retrospective Cohort Study

自身免疫性甲状腺炎与颈动脉夹层之间的关联:一项回顾性队列研究

阅读:1

Abstract

BACKGROUND AND AIMS: Limited evidence suggests autoimmune thyroiditis (AT) could represent a risk factor for cervical artery dissection (CeAD). We tested the hypothesis of a positive association between AT and CeAD within 3 years following diagnosis compared to matched euthyroid controls. METHODS: We searched a de-identified United States' data resource (TriNetX LLC) for adults age ≥ 18 with newly-diagnosed AT, and euthyroid controls, from 2014 to 2024. Propensity matching controlled for variables associated with CeAD. Our primary outcome was the risk ratio (RR) for CeAD within 3 years' follow-up. Secondary outcomes explored the cumulative incidence of CeAD and RRs for vertebral and carotid artery dissection and stroke. RESULTS: After matching, there were 143,831 patients per cohort (80% female). Comparing the AT cohort to matched euthyroid controls, the incidence and risk of CeAD was significantly greater [95% CI] (0.040% vs. 0.025%; RR = 1.58 [1.04, 2.40]; p = 0.029). Secondary outcomes included a non-significant increase in incidence and risk of vertebral artery dissection (0.022% vs. 0.017%; RR = 1.28 [0.76, 2.16]; p = 0.354), and significant increase in incidence and risk of carotid artery dissection (0.019% vs. 0.008%; RR = 2.33 [1.19, 4.59]; p = 0.011) and stroke (2.1% vs. 1.3%; RR = 1.67 [1.58, 1.77]; p < 0.001). Cumulative incidence of CeAD in patients with AT highlighted a time-dependent increase relative to euthyroid controls. CONCLUSION: The present findings suggest that AT is a risk factor for CeAD. Additional research is needed to corroborate these findings and clarify factors that may mediate the AT-CeAD association, such as medications, thyroid hormones, and antibody levels.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。